Investor Information

 

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the TSX Venture Exchange (TLT-TSVX) and the OTCQX (TLTFF).

Number of common shares outstanding

Basic: 126,481,526

Fully Diluted: 166,159,601

Insider Ownership: 6.9% (10.9% fully diluted)

Financial Filings

 
Downloaded 7 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
 
SEDAR Filings (System for Electronic Document Analysis and Retrieval)

Theralase's complete public securities documents are available in English and French on SEDAR.